Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TGP capsules for primary Sjögren's syndrome
ChiCTR-TRC-12002325Phase 4Completed
- Sponsor
- China-Japan friendship Hospital Department of Rheumatism
- Start
- Mar 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of total glucosides of paeony in primary Sjögren's syndrome (2 arms), sponsored by China-Japan friendship Hospital Department of Rheumatism. Primary endpoints: EULAR Sjögren's Syndrome Patient Reported Index and EULAR Sjögren's Syndrome Disease Activity Index. Started Mar 2012; status: completed.
02
Drugs
total glucosides of paeony
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on ChiCTR-TRC-12002325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002325.